J. Burggraaf et al., Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol, THYROID, 11(2), 2001, pp. 153-160
Hyperthyroidism is associated with a higher incidence of arterial thromboem
bolism; increasing age, atrial fibrillation, and mitral valve abnormalities
are risk factors. However, the contribution of endogenous coagulation para
meters is unclear. Because thyroid hormone influences receptor and transcri
ption factors, it can be expected that it will influence proteins involved
in coagulation processes synthetised in many cells.
Fourteen hyperthyroid patients were studied untreated, after 1 week of trea
tment with propranolol, and after therapeutic treatment with thiamazol. Fou
rteen matched controls were used for comparison. On each occasion, endothel
ial marker proteins, coagulation/fibrinolysis factors, and inflammatory (li
ver) markers were measured.
Excess thyroid hormone was associated with elevated levels of most endothel
ium-associated proteins. In addition, plasma fibronectin and fibrinogen wer
e increased, while plasminogen was decreased. No evidence was found that hy
perthyroidism was associated with coagulation/fibrinolysis activation, or w
ith increased levels of the inflammation markers interleukin-6 (IL-6), tumo
r necrosis factor-alpha (TNF-alpha) or C-reactive protein (CRP). Propranolo
l treatment only lowered the von Willebrand factor propeptide, and slightly
increased plasminogen. Treatment with thiamazol returned all parameters to
normal. Hyperthyroidism increased the plasma levels of most endothelial ma
rker proteins, and of some liver-synthetized proteins. No evidence for coag
ulation/fibrinolysis activation was found. However, it appears that endothe
lial activation, which is indicative of a procoagulant state, is present in
hyperthyroidism. This may explain the association between hyperthyroidism
and thromboembolism especially if other risk factors are present. von Wille
brand factor II (vWF:Ag-II) levels may be suitable markers to evaluate acut
e changes in endothelial function because this parameter responds more rapi
dly to changes in endothelial function than other factors.